Ignite Creation Date:
2024-05-06 @ 5:42 PM
Last Modification Date:
2024-10-26 @ 2:33 PM
Study NCT ID:
NCT05397535
Status:
RECRUITING
Last Update Posted:
2023-09-13
First Post:
2022-05-20
Brief Title:
Baduanjin Lower Elevated Blood PreSsure Study
Sponsor:
China National Center for Cardiovascular Diseases
Organization:
China National Center for Cardiovascular Diseases
Study Overview
Official Title:
Traditional Exercise as Convenient Approach to Improve Health 1-Baduanjin Lower Elevated Blood PreSsure Study
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
BLESS
Brief Summary:
The aim of this study is to evaluate the effects of Baduanjin on blood pressure in individuals with high normal blood pressure SBP 130-139 mmHg andor DBP 85-89 mmHg as well as on glucose and lipid metabolism quality of life psychology exercise immune inflammation endothelial function and arterial stiffness
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None